Renal Disease Market - Global Outlook and Forecast 2021-2027

Code: RW00014596058
Market Monitor Global
Nov-2021
Life Sciences
93 Pages

This report contains market size and forecasts of Renal Disease in Global, including the following market information:
Global Renal Disease Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global top five companies in 2020 (%)
The global Renal Disease market was valued at 100100 million in 2020 and is projected to reach US$ 114560 million by 2027, at a CAGR of 3.4% during the forecast period.
Publisher has surveyed the Renal Disease companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Renal Disease Market, By Type, 2016-2021, 2022-2027 ($ millions)
Global Renal Disease Market Segment Percentages, By Type, 2020 (%)
Acute Kidney Problems
Chronic Kidney Diseases
Others

China Renal Disease Market, By Application, 2016-2021, 2022-2027 ($ millions)
China Renal Disease Market Segment Percentages, By Application, 2020 (%)
Hospital
Clinic
Research Center
Others

Global Renal Disease Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)
Global Renal Disease Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Total Renal Disease Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)
Total Renal Disease Market Competitors Revenues Share in Global, by Players 2020 (%)
Further, the report presents profiles of competitors in the market, including the following:
Abbott (US)
Amgen Inc. (US)
Baxter (US)
Bristol-Myers Squibb Company (US)
Keryx Biopharmaceuticals(US)
NephroGenex(US)
Novartis AG (Switzerland)
Pfizer Inc.(US)
Sanofi (France)
Shire Pharmaceuticals Limited (Republic of Ireland)

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Renal Disease Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Renal Disease Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Renal Disease Overall Market Size
2.1 Global Renal Disease Market Size: 2021 VS 2027
2.2 Global Renal Disease Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Renal Disease Players in Global Market
3.2 Top Global Renal Disease Companies Ranked by Revenue
3.3 Global Renal Disease Revenue by Companies
3.4 Top 3 and Top 5 Renal Disease Companies in Global Market, by Revenue in 2020
3.5 Global Companies Renal Disease Product Type
3.6 Tier 1, Tier 2 and Tier 3 Renal Disease Players in Global Market
3.6.1 List of Global Tier 1 Renal Disease Companies
3.6.2 List of Global Tier 2 and Tier 3 Renal Disease Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Renal Disease Market Size Markets, 2021 & 2027
4.1.2 Acute Kidney Problems
4.1.3 Chronic Kidney Diseases
4.1.4 Others
4.2 By Type - Global Renal Disease Revenue & Forecasts
4.2.1 By Type - Global Renal Disease Revenue, 2016-2021
4.2.2 By Type - Global Renal Disease Revenue, 2022-2027
4.2.3 By Type - Global Renal Disease Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Renal Disease Market Size, 2021 & 2027
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Research Center
5.1.5 Others
5.2 By Application - Global Renal Disease Revenue & Forecasts
5.2.1 By Application - Global Renal Disease Revenue, 2016-2021
5.2.2 By Application - Global Renal Disease Revenue, 2022-2027
5.2.3 By Application - Global Renal Disease Revenue Market Share, 2016-2027
6 Sights by Region
6.1 By Region - Global Renal Disease Market Size, 2021 & 2027
6.2 By Region - Global Renal Disease Revenue & Forecasts
6.2.1 By Region - Global Renal Disease Revenue, 2016-2021
6.2.2 By Region - Global Renal Disease Revenue, 2022-2027
6.2.3 By Region - Global Renal Disease Revenue Market Share, 2016-2027
6.3 North America
6.3.1 By Country - North America Renal Disease Revenue, 2016-2027
6.3.2 US Renal Disease Market Size, 2016-2027
6.3.3 Canada Renal Disease Market Size, 2016-2027
6.3.4 Mexico Renal Disease Market Size, 2016-2027
6.4 Europe
6.4.1 By Country - Europe Renal Disease Revenue, 2016-2027
6.4.2 Germany Renal Disease Market Size, 2016-2027
6.4.3 France Renal Disease Market Size, 2016-2027
6.4.4 U.K. Renal Disease Market Size, 2016-2027
6.4.5 Italy Renal Disease Market Size, 2016-2027
6.4.6 Russia Renal Disease Market Size, 2016-2027
6.4.7 Nordic Countries Renal Disease Market Size, 2016-2027
6.4.8 Benelux Renal Disease Market Size, 2016-2027
6.5 Asia
6.5.1 By Region - Asia Renal Disease Revenue, 2016-2027
6.5.2 China Renal Disease Market Size, 2016-2027
6.5.3 Japan Renal Disease Market Size, 2016-2027
6.5.4 South Korea Renal Disease Market Size, 2016-2027
6.5.5 Southeast Asia Renal Disease Market Size, 2016-2027
6.5.6 India Renal Disease Market Size, 2016-2027
6.6 South America
6.6.1 By Country - South America Renal Disease Revenue, 2016-2027
6.6.2 Brazil Renal Disease Market Size, 2016-2027
6.6.3 Argentina Renal Disease Market Size, 2016-2027
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Renal Disease Revenue, 2016-2027
6.7.2 Turkey Renal Disease Market Size, 2016-2027
6.7.3 Israel Renal Disease Market Size, 2016-2027
6.7.4 Saudi Arabia Renal Disease Market Size, 2016-2027
6.7.5 UAE Renal Disease Market Size, 2016-2027
7 Players Profiles
7.1 Abbott (US)
7.1.1 Abbott (US) Corporate Summary
7.1.2 Abbott (US) Business Overview
7.1.3 Abbott (US) Renal Disease Major Product Offerings
7.1.4 Abbott (US) Renal Disease Revenue in Global (2016-2021)
7.1.5 Abbott (US) Key News
7.2 Amgen Inc. (US)
7.2.1 Amgen Inc. (US) Corporate Summary
7.2.2 Amgen Inc. (US) Business Overview
7.2.3 Amgen Inc. (US) Renal Disease Major Product Offerings
7.2.4 Amgen Inc. (US) Renal Disease Revenue in Global (2016-2021)
7.2.5 Amgen Inc. (US) Key News
7.3 Baxter (US)
7.3.1 Baxter (US) Corporate Summary
7.3.2 Baxter (US) Business Overview
7.3.3 Baxter (US) Renal Disease Major Product Offerings
7.3.4 Baxter (US) Renal Disease Revenue in Global (2016-2021)
7.3.5 Baxter (US) Key News
7.4 Bristol-Myers Squibb Company (US)
7.4.1 Bristol-Myers Squibb Company (US) Corporate Summary
7.4.2 Bristol-Myers Squibb Company (US) Business Overview
7.4.3 Bristol-Myers Squibb Company (US) Renal Disease Major Product Offerings
7.4.4 Bristol-Myers Squibb Company (US) Renal Disease Revenue in Global (2016-2021)
7.4.5 Bristol-Myers Squibb Company (US) Key News
7.5 Keryx Biopharmaceuticals(US)
7.5.1 Keryx Biopharmaceuticals(US) Corporate Summary
7.5.2 Keryx Biopharmaceuticals(US) Business Overview
7.5.3 Keryx Biopharmaceuticals(US) Renal Disease Major Product Offerings
7.5.4 Keryx Biopharmaceuticals(US) Renal Disease Revenue in Global (2016-2021)
7.5.5 Keryx Biopharmaceuticals(US) Key News
7.6 NephroGenex(US)
7.6.1 NephroGenex(US) Corporate Summary
7.6.2 NephroGenex(US) Business Overview
7.6.3 NephroGenex(US) Renal Disease Major Product Offerings
7.6.4 NephroGenex(US) Renal Disease Revenue in Global (2016-2021)
7.6.5 NephroGenex(US) Key News
7.7 Novartis AG (Switzerland)
7.7.1 Novartis AG (Switzerland) Corporate Summary
7.7.2 Novartis AG (Switzerland) Business Overview
7.7.3 Novartis AG (Switzerland) Renal Disease Major Product Offerings
7.4.4 Novartis AG (Switzerland) Renal Disease Revenue in Global (2016-2021)
7.7.5 Novartis AG (Switzerland) Key News
7.8 Pfizer Inc.(US)
7.8.1 Pfizer Inc.(US) Corporate Summary
7.8.2 Pfizer Inc.(US) Business Overview
7.8.3 Pfizer Inc.(US) Renal Disease Major Product Offerings
7.8.4 Pfizer Inc.(US) Renal Disease Revenue in Global (2016-2021)
7.8.5 Pfizer Inc.(US) Key News
7.9 Sanofi (France)
7.9.1 Sanofi (France) Corporate Summary
7.9.2 Sanofi (France) Business Overview
7.9.3 Sanofi (France) Renal Disease Major Product Offerings
7.9.4 Sanofi (France) Renal Disease Revenue in Global (2016-2021)
7.9.5 Sanofi (France) Key News
7.10 Shire Pharmaceuticals Limited (Republic of Ireland)
7.10.1 Shire Pharmaceuticals Limited (Republic of Ireland) Corporate Summary
7.10.2 Shire Pharmaceuticals Limited (Republic of Ireland) Business Overview
7.10.3 Shire Pharmaceuticals Limited (Republic of Ireland) Renal Disease Major Product Offerings
7.10.4 Shire Pharmaceuticals Limited (Republic of Ireland) Renal Disease Revenue in Global (2016-2021)
7.10.5 Shire Pharmaceuticals Limited (Republic of Ireland) Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. Renal Disease Market Opportunities & Trends in Global Market
Table 2. Renal Disease Market Drivers in Global Market
Table 3. Renal Disease Market Restraints in Global Market
Table 4. Key Players of Renal Disease in Global Market
Table 5. Top Renal Disease Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Renal Disease Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Renal Disease Revenue Share by Companies, 2016-2021
Table 8. Global Companies Renal Disease Product Type
Table 9. List of Global Tier 1 Renal Disease Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Renal Disease Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type - Global Renal Disease Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Renal Disease Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Renal Disease Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application - Global Renal Disease Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Renal Disease Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Renal Disease Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region - Global Renal Disease Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Renal Disease Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Renal Disease Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Renal Disease Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Renal Disease Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Renal Disease Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Renal Disease Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Renal Disease Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Renal Disease Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Renal Disease Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Renal Disease Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Renal Disease Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Renal Disease Revenue, (US$, Mn), 2022-2027
Table 30. Abbott (US) Corporate Summary
Table 31. Abbott (US) Renal Disease Product Offerings
Table 32. Abbott (US) Renal Disease Revenue (US$, Mn), (2016-2021)
Table 33. Amgen Inc. (US) Corporate Summary
Table 34. Amgen Inc. (US) Renal Disease Product Offerings
Table 35. Amgen Inc. (US) Renal Disease Revenue (US$, Mn), (2016-2021)
Table 36. Baxter (US) Corporate Summary
Table 37. Baxter (US) Renal Disease Product Offerings
Table 38. Baxter (US) Renal Disease Revenue (US$, Mn), (2016-2021)
Table 39. Bristol-Myers Squibb Company (US) Corporate Summary
Table 40. Bristol-Myers Squibb Company (US) Renal Disease Product Offerings
Table 41. Bristol-Myers Squibb Company (US) Renal Disease Revenue (US$, Mn), (2016-2021)
Table 42. Keryx Biopharmaceuticals(US) Corporate Summary
Table 43. Keryx Biopharmaceuticals(US) Renal Disease Product Offerings
Table 44. Keryx Biopharmaceuticals(US) Renal Disease Revenue (US$, Mn), (2016-2021)
Table 45. NephroGenex(US) Corporate Summary
Table 46. NephroGenex(US) Renal Disease Product Offerings
Table 47. NephroGenex(US) Renal Disease Revenue (US$, Mn), (2016-2021)
Table 48. Novartis AG (Switzerland) Corporate Summary
Table 49. Novartis AG (Switzerland) Renal Disease Product Offerings
Table 50. Novartis AG (Switzerland) Renal Disease Revenue (US$, Mn), (2016-2021)
Table 51. Pfizer Inc.(US) Corporate Summary
Table 52. Pfizer Inc.(US) Renal Disease Product Offerings
Table 53. Pfizer Inc.(US) Renal Disease Revenue (US$, Mn), (2016-2021)
Table 54. Sanofi (France) Corporate Summary
Table 55. Sanofi (France) Renal Disease Product Offerings
Table 56. Sanofi (France) Renal Disease Revenue (US$, Mn), (2016-2021)
Table 57. Shire Pharmaceuticals Limited (Republic of Ireland) Corporate Summary
Table 58. Shire Pharmaceuticals Limited (Republic of Ireland) Renal Disease Product Offerings
Table 59. Shire Pharmaceuticals Limited (Republic of Ireland) Renal Disease Revenue (US$, Mn), (2016-2021)
List of Figures
Figure 1. Renal Disease Segment by Type
Figure 2. Renal Disease Segment by Application
Figure 3. Global Renal Disease Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Renal Disease Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Renal Disease Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Renal Disease Revenue in 2020
Figure 8. By Type - Global Renal Disease Revenue Market Share, 2016-2027
Figure 9. By Application - Global Renal Disease Revenue Market Share, 2016-2027
Figure 10. By Region - Global Renal Disease Revenue Market Share, 2016-2027
Figure 11. By Country - North America Renal Disease Revenue Market Share, 2016-2027
Figure 12. US Renal Disease Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Renal Disease Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Renal Disease Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Renal Disease Revenue Market Share, 2016-2027
Figure 16. Germany Renal Disease Revenue, (US$, Mn), 2016-2027
Figure 17. France Renal Disease Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Renal Disease Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Renal Disease Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Renal Disease Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Renal Disease Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Renal Disease Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Renal Disease Revenue Market Share, 2016-2027
Figure 24. China Renal Disease Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Renal Disease Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Renal Disease Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Renal Disease Revenue, (US$, Mn), 2016-2027
Figure 28. India Renal Disease Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Renal Disease Revenue Market Share, 2016-2027
Figure 30. Brazil Renal Disease Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Renal Disease Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Renal Disease Revenue Market Share, 2016-2027
Figure 33. Turkey Renal Disease Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Renal Disease Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Renal Disease Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Renal Disease Revenue, (US$, Mn), 2016-2027
Figure 37. Abbott (US) Renal Disease Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. Amgen Inc. (US) Renal Disease Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Baxter (US) Renal Disease Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. Bristol-Myers Squibb Company (US) Renal Disease Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. Keryx Biopharmaceuticals(US) Renal Disease Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. NephroGenex(US) Renal Disease Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. Novartis AG (Switzerland) Renal Disease Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 44. Pfizer Inc.(US) Renal Disease Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 45. Sanofi (France) Renal Disease Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 46. Shire Pharmaceuticals Limited (Republic of Ireland) Renal Disease Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

Abbott (US)
Amgen Inc. (US)
Baxter (US)
Bristol-Myers Squibb Company (US)
Keryx Biopharmaceuticals(US)
NephroGenex(US)
Novartis AG (Switzerland)
Pfizer Inc.(US)
Sanofi (France)
Shire Pharmaceuticals Limited (Republic of Ireland)

First Name *

Last Name

Country *

E-mail *

Contact No *

Company Name*

Job Title*

Comments

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Have a Question?

EMAIL US

RELATED PRODUCTS

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

View All New Reports

Global Freckle-removing Medical and Beau.. The global market for Freckle-removing Medical and Beauty Eq..

Global Wall Mounted Sinks Market Growth .. The sink is a trough-shaped appliance used to receive kitche..

Global Peripheral Imaging Catheter Marke.. The Peripheral Imaging Catheter's unique design provides exc..

Global Hemostatic Valves and Accessories.. Haemostatic valve prevents blood reflux when a catheter is i..

Global Liver Cancer Treatment Drug Marke.. The global market for Liver Cancer Treatment Drug is estimat..

Global Hypertensive Heart Disease Drug M.. The global market for Hypertensive Heart Disease Drug is est..

Global Urinary Incontinence Drug Market .. The global market for Urinary Incontinence Drug is estimated..

Global Pet Antibiotic Market Growth 2022.. The global market for Pet Antibiotic is estimated to increas..

Global Hemorrhagic Disease Detection Mar.. The global market for Hemorrhagic Disease Detection is estim..

Global Cell Dissociation Solution Market.. The global market for Cell Dissociation Solution is estimate..

Global Cell Detachment and Dissociation .. The global market for Cell Detachment and Dissociation Solut..

Global Cell Detachment Solution Market G.. The global market for Cell Detachment Solution is estimated ..

CUSTOM RESEARCH

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

LEARN MORE